Hend M. El Tayebi, Full Professor and Director of Pharmacoeconomics Diploma Program at The German University in Cairo, shared on LinkedIn:
“GEPPMA-MTB | Meet Our Distinguished Speakers
We are delighted to introduce Prof. Dr. Waleed Arafat as one of the distinguished experts joining the 2nd GEPPMA Molecular Tumor Board (MTB) at the 5th Annual GEPPMA Conference.
GEPPMA GUC | The German University in Cairo
- Prof. Dr. Waleed Arafat
Professor of Clinical Oncology, Alexandria University
Consultant and Cancer Care Expert
Alexandria Comprehensive Cancer Center
With extensive experience in clinical oncology and translational cancer research, Prof. Arafat has contributed to research spanning molecular oncology, personalized treatment, targeted therapies, gene therapy, cancer prevention, and biomarker-driven cancer care.
His work includes collaborative research in colorectal cancer, breast cancer, head and neck cancer, and other malignancies. (ORCID)
Why his participation matters to our MTB
The Molecular Tumor Board represents the ultimate intersection of clinical oncology, molecular diagnostics, genomics, and personalized medicine – bringing together experts to explore how molecular and clinical information can inform therapeutic decision-making.
Prof. Arafat’s expertise in personalized treatment and molecularly driven oncology adds an important clinical perspective to this multidisciplinary experience.
The 2nd GEPPMA Molecular Tumor Board
Following the success of our first MTB, GEPPMA is bringing together prominent oncology and precision-medicine experts to demonstrate how a real-world Molecular Tumor Board works – from understanding the patient and disease characteristics to integrating molecular findings into a personalized therapeutic strategy.
- From molecular data to clinical decisions.
- From precision oncology to personalized patient care.
- October 15th, 2026
- German University in Cairo (GUC)
Want to represent your research with a poster?
Submit your poster through the Poster Submission Form. Submission deadline: 25th September
Want to attend the meeting?
Register through the Meeting Registration Form.
Registration deadline: 30th September.”
Waleed Arafat, President of ISCO and Professor of Clinical Oncology at University of Alexandria, shared Hend M. El Tayebi’s post, adding:
“Great pleasure to give a talk on this special sofosticated conference.”
This might be interesting:
Non-Hodgkin Lymphoma (NHL): A Practical Biological Map and Integrative Overview
